Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
Tags:
R&D
,
Roche
,
JNJ
,
Merck
,
Pfizer
,
Novartis
,
AstraZeneca
,
Bristol Myers Squibb
,
Eli Lilly
,
Sanofi
,
AbbVie
Lazertinib and Tagrisso go head to head
EP Vantage
Fri, 03/24/23 - 10:01 am
Tags:
AstraZeneca
,
lazertinib
,
Tagrisso
,
JNJ
,
lung cancer
After appeals loss, Johnson & Johnson will take Texas two-step case to the US Supreme Court
Fierce Pharma
Wed, 03/22/23 - 09:15 pm
Tags:
JNJ
,
legal
,
Supreme Court
,
bankruptcy
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
Endpoints
Mon, 03/20/23 - 09:50 am
Tags:
JNJ
,
legal
,
Remicade
,
antitrust
,
biosimilars
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
CP WIre
Sat, 03/18/23 - 03:37 pm
Tags:
Medtronic
,
Medtech
,
inflation
,
drug pricing
,
Pfizer
,
Novartis
,
Merck
,
Bristol Myers Squibb
,
Keytruda
,
Opdivo
,
Yervoy
,
lung cancer
,
Xiidra
,
JNJ
,
executive compensation
Sat, 03/18/23 - 03:34 pm
Tags:
Medtronic
,
Medtech
,
inflation
,
drug pricing
,
Pfizer
,
Novartis
,
Merck
,
Bristol Myers Squibb
,
Keytruda
,
Opdivo
,
Yervoy
,
lung cancer
,
Xiidra
,
JNJ
,
executive compensation
Johnson & Johnson shelves Carvykti's UK launch amid manufacturing shortfalls
Fierce Pharma
Wed, 03/15/23 - 09:27 pm
Tags:
JNJ
,
Legend Biotech
,
CAR-T
,
Carvykti
In his first year as Johnson & Johnson CEO, Duato scored $13.1M payout
Fierce Pharma
Wed, 03/15/23 - 12:03 pm
Tags:
Joaquin Duato
,
JNJ
,
Pharma CEOs
,
executive compensation
J&J lays off 350 people at robotics units, says ‘we have to get better’ with Ottava
Medtech Dive
Fri, 03/10/23 - 11:30 am
Tags:
JNJ
,
layoffs
,
robotic surgery
,
Auris Health
,
Verb Surgical
,
Ottava
Johnson & Johnson is cutting jobs in its MedTech business
Mass Device
Tue, 03/7/23 - 10:30 pm
Tags:
JNJ
,
layoffs
,
Medtech
J&J-backed startup launches with $100M to build better brain drugs
BioPharma Dive
Tue, 03/7/23 - 11:14 am
Tags:
Rapport Therapeutics
,
JNJ
,
Neuroscience
,
neurological disorders
ACC23: J&J's combo pill of Opsumit plus tadalafil improves blood flow in PAH patients
Fierce Pharma
Mon, 03/6/23 - 10:51 am
Tags:
JNJ
,
ACC
,
Opsumit
,
Opsynvi
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Fierce Pharma
Fri, 03/3/23 - 11:56 am
Tags:
JNJ
,
patents
,
Janssen
,
Amgen
,
biosimilars
,
Stelara
Spotlight – What is next in Nash
EP Vantage
Fri, 03/3/23 - 10:02 am
Tags:
NASH
,
clinical trials
,
89Bio
,
Arrowhead Pharmaceuticals
,
Can-Fite BioPharma
,
Ewopharma
,
Hepagene Therapeutics
,
JNJ
,
Ligand Pharmaceuticals
,
Madrigal Pharmaceuticals
,
Merck
,
NGM Biopharmaceuticals
,
NorthSea Therapeutics
,
Novartis
,
Sagimet Biosciences
,
Terns Pharmaceuticals
,
Viking Therapeutics
Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients
BioPharma Dive
Thu, 03/2/23 - 10:41 pm
Tags:
Bristol Myers Squibb
,
JNJ
,
clinical trials
,
Librexia
,
bloodthinners
Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report
Fierce Pharma
Tue, 02/28/23 - 10:39 pm
Tags:
Medicare
,
drug pricing
,
Merck
,
Novo Nordisk
,
Eli Lilly
,
Boehringer Ingelheim
,
JNJ
After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year
Fierce Biotech
Mon, 02/27/23 - 10:09 am
Tags:
JNJ
,
Janssen
,
nipocalimab
,
Momenta Pharmaceuticals
J&J wins EU backing for PARP combo Akeega in prostate cancer—but only in some patients
Fierce Pharma
Sun, 02/26/23 - 10:14 pm
Tags:
JNJ
,
Akeega
,
prostate cancer
,
PARP inhibitors
J&J to impose new limits on 340B access after industry court win
Endpoints
Wed, 02/22/23 - 06:57 pm
Tags:
JNJ
,
340B
,
legal
Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table
Fierce Pharma
Wed, 02/22/23 - 06:54 pm
Tags:
Gilead Sciences
,
legal
,
HIV
,
antitrust
,
Teva Pharmaceutical
,
JNJ
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.